VDAC1 regulates disulfidptosis susceptibility and associates with the immune microenvironment via multi-omics analysis in lung adenocarcinoma
A multi-omics analysis of lung adenocarcinoma (LUAD) identifies VDAC1 as a key biomarker associated with poor prognosis and therapy resistance. The study links VDAC1 to disulfidptosis and an immunosuppressive tumor microenvironment.
Why it matters
Identifying VDAC1 as a therapeutic target could lead to more effective treatments for lung cancer patients who currently face high mortality rates.
Scientific Reports ( 2026 ) Cite this article
We’re sharing this article early to provide faster access to peer-reviewed, accepted research. It is citable and carries a permanent DOI. This version is subject to further edits and will be replaced automatically by the final Version of Record. All legal disclaimers apply.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in